{"id":"https://openalex.org/W2554749428","doi":"https://doi.org/10.1182/blood.v126.23.3791.3791","title":"Securinine Targets Cancer Cells through an Irak and JNK Dependent Pathway","display_name":"Securinine Targets Cancer Cells through an Irak and JNK Dependent Pathway","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2554749428","doi":"https://doi.org/10.1182/blood.v126.23.3791.3791","mag":"2554749428"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.3791.3791","doi":"https://doi.org/10.1182/blood.v126.23.3791.3791","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3791.3791","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Kalpana Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kalpana Gupta","raw_affiliation_strings":["Pathology, Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006890981","display_name":"Gary Parizher","orcid":"https://orcid.org/0000-0002-5568-3385","observed_orcids":["https://orcid.org/0000-0002-5568-3385"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Parizher","raw_affiliation_strings":["Pathology, Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034264716","display_name":"Marcos J. G. De Lima","orcid":"https://orcid.org/0000-0002-8568-4522","observed_orcids":["https://orcid.org/0000-0002-8568-4522"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210119077","display_name":"University Hospitals Seidman Cancer Center","ror":"https://ror.org/02kb97560","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcos De Lima","raw_affiliation_strings":["Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I4210119077"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005791561","display_name":"David N. Wald","orcid":"https://orcid.org/0000-0002-8695-1178","observed_orcids":["https://orcid.org/0000-0002-8695-1178"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4390039247","display_name":"Case Comprehensive Cancer Center","ror":"https://ror.org/00fpjq451","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039247","https://openalex.org/I58956616"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David N. Wald","raw_affiliation_strings":["Department of Pathology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH","Pathology, University Hospitals Case Medical Center, cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I4390039247","https://openalex.org/I58956616"]},{"raw_affiliation_string":"Pathology, University Hospitals Case Medical Center, cleveland, OH","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I58956616"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.28123396,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"126","issue":"23","first_page":"3791","last_page":"3791"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.2134999930858612,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.2134999930858612,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.15539999306201935,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.08609999716281891,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/securinine","display_name":"securinine","score":0.7590000033378601},{"id":"https://openalex.org/keywords/irak1","display_name":"IRAK1","score":0.7689999938011169},{"id":"https://openalex.org/keywords/traf6","display_name":"TRAF6","score":0.8709999918937683},{"id":"https://openalex.org/keywords/jnk-signaling","display_name":"JNK signaling","score":0.7680000066757202},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8370000123977661},{"id":"https://openalex.org/keywords/ap-1","display_name":"AP-1","score":0.7509999871253967},{"id":"https://openalex.org/keywords/p53-loss","display_name":"p53 deficiency","score":0.6389999985694885},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7760000228881836},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.8270000219345093},{"id":"https://openalex.org/keywords/plant-derived-anticancer-agents","display_name":"plant-derived anticancer agents","score":0.6399999856948853},{"id":"https://openalex.org/keywords/tumor-cell-death","display_name":"cancer cell death","score":0.6370000243186951},{"id":"https://openalex.org/keywords/kinase-independent-signaling","display_name":"kinase-independent signaling","score":0.3050000071525574},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.3100000023841858},{"id":"https://openalex.org/keywords/innate-immune-signaling","display_name":"innate immune signaling","score":0.38600000739097595},{"id":"https://openalex.org/keywords/differentiation-therapy","display_name":"differentiation therapy","score":0.4009999930858612},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5483629107475281},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5131457448005676},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5032224059104919},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48816877603530884},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4337362051010132},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.42653828859329224},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4214785695075989},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4165356457233429},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2461535632610321},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.21786731481552124},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1810457706451416}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.3791.3791","doi":"https://doi.org/10.1182/blood.v126.23.3791.3791","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3791.3791","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4293198893","https://openalex.org/W2160469216","https://openalex.org/W2014995081","https://openalex.org/W2005977722","https://openalex.org/W2887834541","https://openalex.org/W2768294271","https://openalex.org/W196065131","https://openalex.org/W2741106274","https://openalex.org/W3174348922","https://openalex.org/W2123453419"],"abstract_inverted_index":{"Abstract":[0],"Securinine":[1],"is":[2,217,318],"a":[3,16,31,71,138,158,171,218,225,258,299,429,434,441],"plant-derived":[4],"alkaloid":[5],"from":[6],"the":[7,49,83,93,115,133,178,189,234,263,281,310,345,369,382,388,415],"securinega":[8],"plant":[9],"that":[10,231,242,329,359,446],"has":[11],"been":[12],"used":[13,170,294],"clinically":[14,72],"as":[15,30,75,137,143,207,254],"therapeutic":[17,33,437],"for":[18,35,166,193,443,450],"primarily":[19],"neurological":[20],"related":[21],"diseases.":[22],"We":[23,169,357],"and":[24,39,51,89,104,186,238,270,353,439],"others":[25],"have":[26],"previously":[27],"identified":[28,200],"securinine":[29,44,59,86,98,119,136,284,341,418],"promising":[32,435],"candidate":[34,438],"Acute":[36],"Myeloid":[37],"Leukemia":[38],"colon":[40],"cancer.":[41],"In":[42,57],"particular,":[43],"was":[45,60,251],"found":[46],"to":[47,62,64,121,162,176,195,285,419],"induce":[48],"differentiation":[50,105],"cell":[52,88,102,123,214,335,343,389],"death":[53,103],"of":[54,67,85,95,97,135,150,174,180,191,244,283,313,315,323,350,371,384,392,402,411,417],"AML":[55],"cells.":[56,422],"addition,":[58],"observed":[61,358],"lead":[63],"preferential":[65],"killing":[66,250,390],"p53":[68,80],"deficient":[69,307],"cells,":[70,185],"beneficial":[73],"strategy":[74,156],"only":[76,126],"cancer":[77,101,122,139,151,213,366,421,451],"cells":[78,192,267,288,308,367],"exhibit":[79,298],"deficiency.":[81],"Despite":[82],"efficacy":[84],"in":[87,99,131,153,183,211,221,365,387],"animal":[90],"model":[91],"systems,":[92],"mechanisms":[94,116,149,312],"action":[96,314],"inducing":[100],"remain":[106],"largely":[107],"unknown.":[108],"Here":[109],"we":[110,326],"report":[111],"significant":[112],"insights":[113],"into":[114,433],"through":[117,368],"which":[118],"leads":[120],"death.":[124,197],"Not":[125],"are":[127],"these":[128,385],"observations":[129],"important":[130,209],"furthering":[132],"development":[134],"therapeutic,":[140],"but":[141],"also":[142,327],"they":[144,394],"shed":[145],"light":[146],"on":[147,305],"novel":[148],"therapeutics":[152],"general.":[154],"Our":[155],"involved":[157],"global":[159],"genetic":[160],"screen":[161,199],"identify":[163],"genes":[164,182],"required":[165],"securinine-mediated":[167,196,212,249,334,408],"killing.":[168,215,336],"pooled":[172],"library":[173],"shRNA":[175,264],"knockdown":[177],"expression":[179],"27,000":[181],"cultured":[184],"then":[187],"screened":[188],"population":[190],"resistance":[194],"This":[198],"interleukin-1":[201],"receptor":[202,223],"associated":[203],"kinase":[204,219],"1":[205],"(IRAK1)":[206],"an":[208,319],"player":[210],"IRAK1":[216,245,274],"acting":[220],"toll-like":[222],"signaling,":[224,325],"key":[226],"innate":[227],"immune":[228],"inflammatory":[229],"pathway":[230],"ultimately":[232],"activates":[233],"transcription":[235],"factors":[236],"AP1":[237],"NFkB.":[239],"The":[240],"fact":[241],"loss":[243],"could":[246],"protect":[247],"against":[248],"quite":[252],"unexpected":[253],"NFkB":[255,352,403],"activation":[256],"provides":[257,426,440],"pro-survival":[259],"signal.":[260],"To":[261,337,380],"confirm":[262],"screen,":[265],"IRAK1\u2212/\u2212":[266],"were":[268,355,362,395],"utilized":[269],"reconstituted":[271],"with":[272,428],"wild-type":[273,290],"or":[275,376],"kinase-deficient":[276],"IRAK1.":[277],"These":[278],"studies":[279],"confirmed":[280],"ability":[282,416],"preferentially":[286],"kill":[287,420],"expressing":[289],"IRAK.":[291],"Interestingly,":[292],"currently":[293],"chemotherapeutics":[295],"did":[296],"not":[297],"similar":[300],"reduced":[301],"sensitivity":[302],"when":[303],"tested":[304],"IRAK":[306,324],"demonstrating":[309],"unique":[311],"securinine.As":[316],"TRAF6":[317,332],"adapter":[320],"protein":[321],"downstream":[322,349],"demonstrated":[328],"dominant":[330],"negative":[331],"impaired":[333,414],"further":[338],"delineate":[339],"how":[340],"induces":[342],"death,":[344],"two":[346],"major":[347],"pathways":[348,361,386,445],"IRAK,":[351],"JNK/AP1":[354],"investigated.":[356],"both":[360],"rapidly":[363],"induced":[364],"use":[370],"gene":[372],"reporter":[373],"assays":[374],"(NFkB)":[375],"western":[377],"blot":[378],"(JNK/AP1).":[379],"assess":[381],"importance":[383],"effects":[391],"securinine,":[393],"inhibited":[396],"using":[397],"chemical":[398],"inhibitors.":[399],"While":[400],"blockade":[401],"had":[404],"no":[405],"impact":[406],"upon":[407],"killing,":[409],"inhibition":[410],"JNK":[412],"dramatically":[413],"Overall,":[423],"this":[424],"study":[425],"us":[427],"greater":[430],"mechanistic":[431],"insight":[432],"new":[436,444],"framework":[442],"can":[447],"be":[448],"targeted":[449],"drug":[452],"development.":[453],"Disclosures":[454],"Wald:":[455],"Invenio":[456],"Therapeutics:":[457],"Equity":[458],"Ownership.":[459]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-11-30T00:00:00"}